The aim of this eCORE is the study of those diseases that have a global impact in society. The groups will promote research diseases that affect a large number of people in order to improve society’s well-being and public health.

This eCORE focuses on the study of chronic and prevalent diseases along people’s life, and the effect of aging in society’s well-being.

The main objectives of this eCORE are the study of diseases that affect women and children, including maternal diseases and paediatric and early ages health issues, as well as rare diseases affecting a small number of people.

Research groups affiliated to this eCORE are focused on the study of diseases affecting the brain, mind and/or behaviour. These clinical conditions have a high personal, social and economic burden, leading to disability and reducing quality and life.

The aim of the Cancer eCORE is to improve the outcome and quality of life of cancer patients. Cancer eCORE directs its efforts to unveil and understand the mechanisms of the cancer origin and progression. The ultimate goal is to translate this knowledge into new diagnostic, prognostic and therapeutic solutions. Our bench to bed comprehensive research includes the generation of relevant disease models, biomarker studies, drug development and clinical trials.

Being the largest, the objective of this eCORE is the development of new diagnostic tools and the promotion of personalized medicine based or not on digital health through the use of molecular imaging and other medical imaging technologies, biochemistry, pharmacy, pathology anatomy, omics data and related disciplines.

This eCORE is focused on the development of novel cutting-edge treatment and interventions, based on advanced therapies, nanomedicine and innovative surgical and transplant/donation procedures, with the clear aim of making such progresses readily available to patients in need.